Highly resistant gram-negative microorganisms: Incidence density and occurrence of nosocomial transmission (TRIANGLe Study)

Infection Control and Hospital Epidemiology

Volumn 32, Issue 4, 2011, Pages 333-341

  Willemsen, Ina ^a   Elberts, S ^a   Verhulst, C ^a   Rijnsburger, M ^b   Filius, M ^c   Savelkoul, P ^b   Kluytmans, J ^a,b   Lommerse, E ^c   Spanjaard, L ^c   Vlaminckx, B ^d   Vos, A ^e   Wulf, M ^f   Vos, M ^g   Wintermans, R ^h   Andriesse, G ⁱ   Van Zeijl, J ^j   Van Der Vorm, E ^k   Buiting, A ^l   Sturm, P ^m   Blok, H ⁿ   Troelstra, A ⁿ   Kaiser, A ^b   Vandenbroucke Grauls, C ^b   more..

^a AMPHIA HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^f CATHARINA HOSPITAL   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h Laboratory for Microbiology and Infection Control   (Netherlands)

ⁱ Laboratory for Microbiology and Infection Control   (Netherlands)

^j MEDICAL CENTER LEEUWARDEN   (Netherlands)

^k REINIER DE GRAAF HOSPITAL   (Netherlands)

^l CPRLab   (Netherlands)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; DISEASE RESISTANCE; EPIDEMIOLOGICAL DATA; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION SENSITIVITY; MOLECULAR TYPING; NONHUMAN; SPECIES IDENTIFICATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE AEROBIC RODS AND COCCI; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS; HOSPITALS, GENERAL; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES;

EID: 79952609655     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/658941     Document Type: Article

References (19)

1. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-485.
2. Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006;42(suppl):S90-S95.
3. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999;96(3):1152-1156. (Pubitemid 29072199)
4. Strausbaugh LJ, Siegel JD, Weinstein RA. Preventing transmission of multidrug resistance bacteria in a healthcare setting. Clin Infect Dis 2006;42(6):828-835. (Pubitemid 43363941)
5. Kluytmans-VandenBergh MFQ, Kluytmans JAJW, Vos A. Dutch guideline for preventing nosocomial transmission of highly resistant micro-organisms (HRMO). Infection 2005;33(5-6):309-313. (Pubitemid 41552005)
6. December Working Party for Infection Control. WIP Guideline: Policy for Highly Resistant Microorganisms, 2005. http://www.wip.nl. Accessed February 18, 2010.
7. Willemsen I, Mooij M, van der Wiel M, et al. Highly resistant microorganisms in a teaching hospital: the role of horizontal spread in a setting of endemicity. Infect Control Hosp Epidemiol 2008;29(12):1110-1117.
8. Vonberg RP, Wolter A, Chaberny IF, Kola A, Ziesing S, Suerbaum S, Gastmeier P. Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period. Int J Hyg Environ Health 2008;211(3-4):251-257. (Pubitemid 351847851)
9. World Health Organization. Guidelines for ATC Classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methology, Norwegian Institute of Public Health; 2002.
10. Stuart JC, Leverstein M, al Naiemi N, members of the ESBL working party from the NVMM. Guideline for screening and confirmation of of extended spectrum beta-lactamases (ESBL) in Enterobacteriaceae. 2008 http://www.nvmm.nl/. Accessed February 18, 2010.
11. Savelkoul PH, Aarts HJ, de Haas J, Dijkshoorn L, Duim B, Otsen M, Rademaker et al. Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 1999;37(10):3083-3091. (Pubitemid 29455186)
12. Zhanel GG, DeCorby M, Laing N, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006. Antimicrob Agents Chemother 2008;52(4):1430-1437. (Pubitemid 351522009)
13. Doi Y, Paterson DL, Egea P, et al. Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 2010;16(1):33-38.
14. SWAB. NethMap 2009: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. http://www.swab.nl/swab/cms3.nsf/uploads/1D61A8F6E60555F3C125763900414B7B/ $FILE/nethmap2009-21-9-2009.pdf. Accessed February 18, 2010.
15. Brooklyn Antibiotic Resistance Task Force. The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on length of hospital stay. Infect Control Hosp Epidemiol 2002;23:106-108.
16. Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze-Roebecke R, Lemmen SW. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay. Infection 2008;36(1):3105.
17. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programma to improve compliance with hand hygiene infection control programme. Lancet 2000;356(9238): 1307-1312.
18. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355(26):2725-2732. (Pubitemid 46021509)
19. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae-producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in nonepidemic situations. Infect Control Hosp Epidemiol 2004;25(10):838-841. (Pubitemid 40036759)